Read the Latest
Toxicologists, health care practitioners, and others are noticing an alarming trend as physicians have begun prescribing fewer opioids: Gabapentin prescriptions and subsequent misuse of the painkiller have increased.
Loren Bonner
Updates from FDA
Ubrogepant (Ubrelvy—Allergan) has received FDA approval as the first oral calcitonin gene-related peptide (CGRP) receptor antagonist for acute treatment of migraine with or without aura in adults.
Cara Aldridge Young
The American Heart Association (AHA) and the American College of Cardiology (ACC) jointly released a set of performance and quality measures for adults with high blood pressure that closely align with AHA/ACC’s blood pressure guidelines published in late 2017.
All pharmacists know that for many conditions, medication isn’t enough. True management of chronic diseases takes a 360° approach that includes exercise, smoking cessation, and—unavoidably—nutrition.
Rachel Balick
EO CEO Blog